Allergic Rhinoconjunctivitis
68
3
3
59
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Research Maturity
59 completed trials (87% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.4%
3 terminated out of 68 trials
95.2%
+8.7% vs benchmark
26%
18 trials in Phase 3/4
17%
10 of 59 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 59 completed trials
Clinical Trials (68)
Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction
Study of BLU-808 in Allergic Rhinoconjunctivitis
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma
Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy.
To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions
Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study
Andosan in Allergic and Asthma Patients
Tolerability of Grazax in Patients With Hayfever in Real Life Settings
Nasal Mucus Proteome and Immunotherapy
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
Effect of holoBLG on Cat Allergic Patients
S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
Adolescent Mite Allergy Safety Evaluation
Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber
Probiotic Chewables in Allergic Rhinoconjunctivitis Patients
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients